MDxHealth SA MDXH

0.57 (0.01) (1.72%) as of 25 Sep
Market cap
$55.5M
P/E
0.0×
Growth Flags show if company had growth for consecutive years,
Insider Buys alert about insiders buying in the last 12 month
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
P/E ratio
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
P/S ratio
1.63 0.86 1.53 0.00 0.00 0.00 0.00 0.00 0.00 0.00
P/FCF ratio
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
P/Operating CF
471.87 (24.98) (14.55) (11.49) 0.00 0.00 0.00 0.00 0.00 0.00
P/B ratio
0.00 5.25 14.88 11.99 0.00 0.00 0.00 0.00 0.00 0.00
Price to Tangible BV
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EV/Sales
2.14 1.00 1.78 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EV/EBITDA
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EV/Operating CF
(106.99) (4.85) (5.80) (3.95) 0.67 0.27 0.27 0.27 0.27 0.27
EV/FCF
(54.25) (4.34) (4.62) (3.65) 0.65 0.27 0.27 0.27 0.27 0.27
Quick Ratio
0.88 1.44 1.71 1.36 3.84 1.51 2.75 3.94 2.79 —
Current Ratio
1.08 1.57 1.95 1.59 4.05 1.77 2.96 4.17 3.00 —
Net Debt/EBITDA
(10.71) (0.71) (0.85) (0.70) 1.84 0.04 0.29 0.88 1.53 0.00
Debt/Assets
57.25% 37.31% 30.81% 32.42% 19.60% 47.44% 25.48% 0.62% 1.51% 0.00%
Debt/Equity
(7.00) 3.96 5.52 4.15 0.31 2.58 0.52 0.01 0.02 —
Asset Turnover
0.71 0.63 0.57 0.38 0.42 0.51 0.22 0.46 1.38 0.00
Operating CF/Net income
0.07 0.49 0.50 0.77 0.78 0.71 0.52 0.88 0.85 0.00
Capex/Depreciation
(0.13) (0.27) (0.73) (0.85) (0.30) (0.16) (0.02) (0.46) (2.58) —
Interest Coverage
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
ROE
(2,440.41%) (345.31%) (521.70%) (156.70%) (109.96%) (224.16%) (119.99%) (67.84%) 0.00% 0.00%
ROA
(21.96%) (26.58%) (34.72%) (45.36%) (54.25%) (79.09%) (81.24%) (52.34%) (42.00%) 0.00%
ROIC
(20.66%) (57.77%) (69.39%) (73.04%) (538.20%) (338.36%) (336.17%) (76.21%) (27.79%) 0.00%
Return on Tangible Assets
(383.95%) (133.13%) (182.67%) (300.40%) (55.94%) (259.55%) (200.03%) (84.51%) (42.71%) 0.00%
Average Days of Receivables
49.65 58.53 57.66 92.17 75.20 74.56 205.81 245.01 178.63 0.00
Research and Development Expense of Revenue
9.59% 11.72% 9.08% 14.84% 30.01% 24.61% 76.34% 15.07% 8.65% 0.00%
Selling, General and Administrative Expense of Revenue
64.42% 70.83% 85.37% 132.27% 143.41% 166.53% 280.06% 157.76% 96.63% 0.00%
Intangible Assets out of Total Assets
0.53 0.49 0.62 0.69 0.05 0.16 0.18 0.24 0.28 0.00
Share Based Compensation of Revenue
2.05% 1.92% 0.95% 2.34% 5.49% 7.02% 7.40% 3.54% 2.33% 0.00%
Graham Net Nets
(0.60) (0.97) (0.78) (0.72) 0.00 0.00 0.00 0.00 0.00 0.00
Graham Number
1.90 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Yield
(18.49%) (53.59%) (40.58%) (65.10%) (65.10%) (65.10%) (65.10%) (65.10%) (65.10%) (65.10%)
Free Cash Flow Yield
(2.42%) (26.57%) (25.14%) (33.03%) 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Revenue per Share
2.16 2.74 2.71 2.34 1.82 2.22 1.89 4.93 8.12 5.91
Operating CF per Share
(0.04) (0.56) (0.83) (2.15) (1.85) (2.43) (3.57) (4.95) (2.09) 0.00
Capex per Share
(0.02) (0.07) (0.19) (0.26) (0.07) (0.06) (0.01) (0.23) (0.97) 0.00
Free Cash Flow per Share
(0.07) (0.63) (1.02) (2.41) (1.92) (2.50) (3.58) (5.19) (3.07) 0.00
Cash per Share
0.58 1.42 0.86 0.98 4.80 1.92 3.53 4.55 3.37 0.00
Shareholders Equity per Share
(0.24) 0.45 0.28 0.59 3.85 0.70 3.16 9.05 8.72 0.00
Interest Debt per Share
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Book value per Share
(0.24) 0.45 0.28 0.59 3.85 0.70 3.16 9.05 8.72 0.00
Free Cash Flow
(3.35) (20.69) (26.52) (38.28) (23.44) (20.78) (22.36) (29.89) (15.31) —
Working Capital
3.88 24.23 18.64 10.87 50.17 10.07 20.48 36.39 26.20 —
Capital Expenditures
(1.16) (2.16) (5.02) (4.16) (0.90) (0.54) (0.07) (1.34) (4.86) —
Net Current Asset Value
(106.64) (75.59) (83.76) (80.67) 38.43 (2.92) 10.00 34.50 24.34 —
EV/EBIT
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Capex to Sales
0.01 0.02 0.07 0.11 0.04 0.03 0.01 0.05 0.12 0.00
Net Profit Margin
(31.07%) (42.28%) (61.40%) (118.86%) (130.41%) (155.27%) (365.72%) (114.27%) (30.33%) (43.96%)
Price to Operating Income
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Other line items
Depreciation/Fixed assets
1.90 1.84 1.38 1.29 1.82 3.42 3.21 1.46 0.73 —
Cash ROIC
(6.93%) (19.02%) (38.13%) (59.76%) (20.16%) (57.47%) (44.81%) (38.81%) (21.25%) —
Accounts Receivable Turnover
7.41 7.05 6.87 5.32 5.32 3.54 0.92 1.46 0.00 0.00
Accounts Payable Turnover
4.17 4.15 2.77 2.02 1.83 2.03 2.06 1.61 0.00 —
Inventory Turnover
7.21 10.50 10.29 8.42 5.51 5.92 7.84 6.25 0.00 —
Average Days of Payables
98.59 83.66 122.45 208.30 233.07 186.42 153.95 202.14 288.16 —
Days of Inventory on Hand
64.34 40.45 38.62 47.62 59.74 81.44 37.01 56.60 68.65 —
Average Receivables
14.56 12.76 10.22 6.97 4.18 5.21 12.85 19.44 — —
Average Payables
9.17 8.41 9.49 8.82 6.39 5.14 5.71 7.25 — —
Average Inventory
5.31 3.32 2.55 2.12 2.12 1.76 1.50 1.86 — —
Average Assets
152.64 143.23 124.13 97.10 53.46 36.24 53.05 62.00 29.26 0.00
Average Common Equity
1.37 11.02 8.26 28.11 26.37 12.79 35.92 47.83 — —

Fold the line items

Columns are period end dates